Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-30

Clinical Trial Update: Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients [NA]

View source ↗

Summary

A completed clinical trial compared tiotropium delivered by the Respimat inhaler versus the HandiHaler in chronic obstructive pulmonary disease patients, assess…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tiotropium (tiotropium)

Snippet

Sponsor: University of Crete | Conditions: Chronic Obstructive Pulmonary Disease | NA | Status: COMPLETED | Results posted: 2017-03-30